Member Info for WeTookPelham

Another uneducated question RE your comment RayP:

"I remember Lindy's initial view on Moditope was that it would not need a CI to work. So perhaps the general approach may be to try monotherapy first. For any patient not responding, perhaps it would be possible, under the right circumstances, to switch them to the equivalent combination group."

To me it almost sounds like Moditope would be better as a mono therapy? And when used in conjuction with a checkpoint inhibitor is possibly worse/holding Moditope back?

Edit...just to add, I feel like the FOMO is kicking in with said "doubters".

It's the same old games over and over. Getting boring.
But yes traders who are out of the share wanting back in at a lower price, it's so obvious, why not just admit it.

To all the doubters, de-rampers and "worriers", if you're so convinced why don't you just sell up and buy back cheaper later... if you dare.

https://www.dailymail.co.uk/health/article-11514349/BQ-1-1-Covid-variant-makes-vaccines-four-times-weaker.html

Thanks WW.

I'll be honest i thought this cohort of three were all head & neck? So i'ts mixed?

@wigwammer - for the less scientific amongst us, ovarian is a big deal because it's hardest to treat?

Yes excellent post RW.
IMO Yes we have had significant news within RNS's (hypersensitivity response to the vaccine), and let's not forget the hugely significant Genmab deal RNS as well.

I would say this rise is due to those RNS's but we had a somewhat delayed reaction. What lit the touch paper is the Macmillan updates confirming the RNS. All IMO.

"The Motley Fool pieces these days could almost be written by robots……"

I'm pretty sure these are automated pieces, written whenever a stock makes X % over a given time period. Looks like it just scrapes generic info about a company and cobbles it together.

I wouldn't pay motley fool any attention anyway, pretty useless.

...not moved up or down for most of the day?

"...There could be more than we think going on behind the scenes with these early read outs!?"

I asked a kind of similar question about this before. You'd think the results are being very closely watched by potential suitors, and not just BionTech but possibly the likes of GenMab etc as well, although BionTech seem to be the most obvious atm.

A potential bidding war?

With RW's astute buy today he will be able to afford a dedicated person to look after his under garments too.

Hmmm...I couldn't see a reason to be suspicious before, but I'm not so sure now. The timing of the question seems a bit off. I sincerely hope WW is a genuine forum user.

A typical Kashdog post IMO.

I agree violndog.

... not results related however. Interesting though.

Lofas, I take it you're trading the share now/sold out and want a dip now?

IMO no one should be relying on the Macmillan thread or any third party source for news for obvious reasons. Another reason is as mentioned they may been asked not update anymore, and even if they are allowed to post I'm sure those posters in focus have more important things to think about and may simply forget to post.

My point/question is simply that Scancell may(?) have to fast track an RNS to preempt leaks.

Patients, their families, nurses, doctors, others working in the hospital will be aware ahead of everyone else.

Edit* sorry Chester18 said it better!